02407.HK
Gaush Meditech Ltd
HKSE · Healthcare · Medical - Devices · CN
HKD 4.64
+5.45%Year over year
Reported trailing growth
- Revenue
- -8.1%
- EBITDA
- -43.2%
- EBIT
- -54.1%
- EPS
- -25.7%
- Free cash flow
- -21.1%
- Operating cash flow
- -21.9%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +3.3%
- EBITDA
- -14.5%
- EBIT
- -20.9%
- Net income
- -25.5%
- EPS
- -24.9%
- Free cash flow
- -16.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026